EMA
approval
· 2014-03-21
European Medicines Agency recommends approval of a locally targeted treatment for ulcerative colitis and Crohn's disease
Summary
The European Medicines Agency recommends approval of a locally targeted treatment for ulcerative colitis and Crohn's disease.
Upgrade for the full analysis, importance score, and drug timeline.